AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Cellectis to Report Q2 2025 Financial Results on August 4, 2025
ByAinvest
Monday, Jul 28, 2025 4:33 pm ET1min read
Cellectis, a clinical-stage biotechnology company, will report its Q2 2025 financial results on August 4, 2025. The company will hold a conference call on August 5, 2025 at 14:00 CET / 8:00 AM ET to discuss the results and update on its activities. The call will be available via phone and webcast.
Paris-based biotechnology company Cellectis (Euronext Growth: ALCLS - Nasdaq: CLLS) has announced that it will publish its financial results for the second quarter ending June 30, 2025, on August 4, 2025, after the close of the U.S. market [1]. The company will also hold an investor conference call and webcast on August 5, 2025, at 14:00 CET / 8:00 AM ET to discuss the Q2 results and provide an update on its business activities [1].Cellectis, a clinical-stage biotechnology company, utilizes its pioneering gene-editing platform TALEN® to develop life-saving cell and gene therapies. The company focuses on allogeneic CAR T immunotherapies in oncology and pioneers the concept of off-the-shelf and ready-to-use gene-edited CAR T-cells for cancer treatment [1][2]. Cellectis also has a platform for developing gene therapies in other therapeutic indications, thanks to its in-house manufacturing capabilities, which allow it to control the cell and gene therapy value chain from start to finish [1][2].
Investors and financial professionals can access the conference call through domestic (+1-800-343-5172) or international (+1-203-518-9856) dial-in numbers using Conference ID: CLLSQ2 [1][2]. The webcast link is available at https://viavid.webcasts.com/starthere.jsp?ei=1727030&tp_key=10a62ee950 [1][2].
Cellectis is listed on the Nasdaq Global Market (ticker: CLLS) and Euronext Growth (ticker: ALCLS) [1][2]. For further information on Cellectis, please visit www.cellectis.com or contact media@cellectis.com [1].
References:
[1] https://www.globenewswire.com/news-release/2025/07/28/3122870/0/fr/Cellectis-publiera-ses-r%C3%A9sultats-financiers-du-deuxi%C3%A8me-trimestre-2025-le-4-ao%C3%BBt-2025.html
[2] https://www.stocktitan.net/news/CLLS/cellectis-to-report-second-quarter-2025-financial-results-on-august-fsw0vxzd4znb.html
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc’s editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet